ArticleGastroenterology2024

Impaired Glycosylation of Gastric Mucins Drives Gastric Tumorigenesis and Serves as a Novel Therapeutic Target.

Junya Arai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.